Envoy Medical (COCH) Income towards Parent Company (2021 - 2026)

Envoy Medical (COCH) has 6 years of Income towards Parent Company data on file, last reported at -$6.2 million in Q1 2026.

• For the quarter ending Q1 2026, Income towards Parent Company fell 11.09% year-over-year to -$6.2 million; the trailing twelve-month figure through Mar 2026 stood at -$24.5 million (up 98.75% YoY), and the FY2025 full-year result was -$23.9 million, up 1.45% from the prior year.
• Income towards Parent Company rose to -$6.2 million in Q1 2026, from -$6.4 million in the prior quarter.
• In the past five years, Income towards Parent Company ranged from a high of $12.5 million in Q1 2022 to a low of -$1.9 billion in Q3 2024.
• A 5-year average of -$115.7 million and a median of -$4.9 million in 2024 frame the typical range for Income towards Parent Company.
• Across the five-year window, Income towards Parent Company jumped 1400.18% in 2022 and plunged 45325.56% in 2024, its largest moves.
• Tracing COCH's Income towards Parent Company over 5 years: stood at -$2.0 million in 2022, then soared by 426.12% to $6.6 million in 2023, then slumped by 175.3% to -$4.9 million in 2024, then retreated by 29.43% to -$6.4 million in 2025, then grew by 2.54% to -$6.2 million in 2026.
• Business Quant data shows COCH's Income towards Parent Company at -$6.2 million in Q1 2026, -$6.4 million in Q4 2025, and -$6.2 million in Q3 2025.